Synthetic Excipients Challenge All-Natural Organics

Vitrakvi (larotrectinib) was first granted accelerated approval by FDA in November 2018.

In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.

Lack of skills in the AI realm was a distant second among those surveyed about the biggest barrier to innovation while using the technology.

In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.

Advanced solutions are improving drug dissolution, absorption, and overall therapeutic performance.

Sitting down with the PharmTech Group at INTERPHEX 2025, Christopher Murphy, director of Global Business Development and Service Customer Support at Environmental Specialties, discusses the design and critical role of walk-in chambers in the bio/pharmaceutical industry.